141 related articles for article (PubMed ID: 23607955)
21. Effect of montelukast on markers of airway remodeling in children with asthma.
Tenero L; Piazza M; Sandri M; Azzali A; Chinellato I; Peroni D; Boner A; Piacentini G
Allergy Asthma Proc; 2016 Sep; 37(5):77-83. PubMed ID: 27657514
[TBL] [Abstract][Full Text] [Related]
22. [Effects of montelukast and BCG-PSN on the expression of STAT5b mRNA and IL-4 mRNA in blood mononuclearcells of rats with asthma].
Jin YJ; Song ZY; Hu Y; Qian XB; Wang XY; He XY
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Feb; 11(2):133-7. PubMed ID: 19222952
[TBL] [Abstract][Full Text] [Related]
23. Effect of montelukast on polymorphonuclear leukocyte functions in asthmatic patients.
Gürer US; Büyüköztürk S; Palandüz S; Gürbüz B; Cevikbaş A
Int Immunopharmacol; 2003 Sep; 3(9):1257-60. PubMed ID: 12890423
[TBL] [Abstract][Full Text] [Related]
24. [Effect of 1,25-(OH)2D3 on expression of HMGB1 and TLR4 in the lungs of asthmatic mice].
Gu HR; Luan B; Qiao JY; Wang YZ; Li Q
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Mar; 16(3):301-5. PubMed ID: 24661526
[TBL] [Abstract][Full Text] [Related]
25. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
Fritscher LG; Rodrigues MT; Zamel N; Chapman KR
Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
[TBL] [Abstract][Full Text] [Related]
26. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
[TBL] [Abstract][Full Text] [Related]
27. [Effects of H2 relaxin on airway remodeling and expression of cyclin D1 in a murine model of chronic asthma].
Han SG; Lü BL; Ding XJ; Zhang J; Huang M
Zhonghua Jie He He Hu Xi Za Zhi; 2012 May; 35(5):349-54. PubMed ID: 22883994
[TBL] [Abstract][Full Text] [Related]
28. Suppression of plasma matrix metalloproteinase-9 following montelukast treatment in childhood asthma.
Chuang SS; Hung CH; Hua YM; Tien CH; Yang KD; Jong YJ; Hsu SH; Lin CS
Pediatr Int; 2007 Dec; 49(6):918-22. PubMed ID: 18045297
[TBL] [Abstract][Full Text] [Related]
29. Leukotriene receptor antagonist attenuated airway inflammation and hyperresponsiveness in a double-stranded RNA-induced asthma exacerbation model.
Ujino M; Sugimoto N; Koizumi Y; Ro S; Kojima Y; Asae KH; Yamashita N; Ohta K; Nagase H
Allergol Int; 2017 Sep; 66S():S21-S26. PubMed ID: 28647381
[TBL] [Abstract][Full Text] [Related]
30. Montelukast in childhood asthma: what is the evidence for its use?
Amlani S; McIvor RA
Expert Rev Respir Med; 2011 Feb; 5(1):17-25. PubMed ID: 21348582
[TBL] [Abstract][Full Text] [Related]
31. [Successful and effective: Montelukast in clinical practice].
Internist (Berl); 1999 Dec; 40(12 Suppl Montelukas):1-4. PubMed ID: 10635479
[No Abstract] [Full Text] [Related]
32. A novel prostacyclin agonist protects against airway hyperresponsiveness and remodeling in mice.
Yamabayashi C; Koya T; Kagamu H; Kawakami H; Kimura Y; Furukawa T; Sakagami T; Hasegawa T; Sakai Y; Matsumoto K; Nakayama M; Gelfand EW; Suzuki E; Narita I
Am J Respir Cell Mol Biol; 2012 Aug; 47(2):170-7. PubMed ID: 22403804
[TBL] [Abstract][Full Text] [Related]
33. [Effect of montelukast on the apoptosis of lymphocytes in asthmatic rats and its molecular mechanism].
Xian L; Liang Z; Liu C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):121-4. PubMed ID: 15600201
[TBL] [Abstract][Full Text] [Related]
34. Montelukast inhibits interleukin-5 mRNA expression and cysteinyl leukotriene production in ragweed and mite-stimulated peripheral blood mononuclear cells from patients with asthma.
Frieri M; Therattil J; Wang SF; Huang CY; Wang YC
Allergy Asthma Proc; 2003; 24(5):359-66. PubMed ID: 14619337
[TBL] [Abstract][Full Text] [Related]
35. Effects of exercise training and montelukast in children with mild asthma.
Bonsignore MR; La Grutta S; Cibella F; Scichilone N; Cuttitta G; Interrante A; Marchese M; Veca M; Virzi' M; Bonanno A; Profita M; Morici G
Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200
[TBL] [Abstract][Full Text] [Related]
36. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
37. [Effect of triptolide on airway remodeling and the expression of phosphoinositide 3-kinases in asthmatic rats].
Mo BW; Wang CM; Zhang ZX; Xu YJ; Xiong WN; Liu XS; Fang CS
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2007 Aug; 23(3):359-64. PubMed ID: 21162285
[TBL] [Abstract][Full Text] [Related]
38. [Effects of different doses of 1,25-(OH)2D3 on expression of HMGB1 and IL-17 in the lungs of asthmatic mice].
Li YL; Luan B; Qiao JY; Zhang LM
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Feb; 17(2):190-5. PubMed ID: 25760848
[TBL] [Abstract][Full Text] [Related]
39. [Effects of NK-1R inhibitor WIN62577 on the migration of airway smooth muscle cells in asthmatic rats with airway remodeling].
Wei B; Liu YL; Zhang C; Shang YX; Zhang H; Li M
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Nov; 17(11):1248-52. PubMed ID: 26575887
[TBL] [Abstract][Full Text] [Related]
40. The leukotriene d4 receptor antagonist, montelukast, inhibits mast cell degranulation in the dermis induced by water avoidance stress.
Cikler E; Ersoy Y; Cetinel S; Ercan F
Acta Histochem; 2009; 111(2):112-8. PubMed ID: 18617226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
